BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30126384)

  • 21. A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis.
    Kheirkhah A; Tabatabaei A; Zavareh MK; Khodabandeh A; Mohammadpour M; Raju VK
    Can J Ophthalmol; 2012 Jun; 47(3):305-11. PubMed ID: 22687313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
    Tan DT; Lee CP; Lim AS
    Ann Acad Med Singap; 1995 Nov; 24(6):823-9. PubMed ID: 8838989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis.
    Robinson A; Kremer I; Avisar R; Gaton D; Savir H; Yassur Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):177-80. PubMed ID: 10090578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.
    Bourcier T; Thomas F; Borderie V; Chaumeil C; Laroche L
    Br J Ophthalmol; 2003 Jul; 87(7):834-8. PubMed ID: 12812878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ; Tirado Balaguer MD; García Zúñiga ED; Granados Ortega J; Campos Aznar A; Moreno Muñoz R
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endophthalmitis caused by Pseudomonas aeruginosa in Taiwan.
    Chen KJ; Sun MH; Lai CC; Wu WC; Chen TL; Kuo YH; Chao AN; Hwang YS; Chen YP; Wang NK; Liu L; Kuo JZ
    Retina; 2011 Jun; 31(6):1193-8. PubMed ID: 21283056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and causative organisms in microbial keratitis.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome.
    Wagoner MD; Al-Swailem SA; Sutphin JE; Zimmerman MB
    Ophthalmology; 2007 Jun; 114(6):1073-9. PubMed ID: 17275089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.
    Ly CN; Pham JN; Badenoch PR; Bell SM; Hawkins G; Rafferty DL; McClellan KA
    Clin Exp Ophthalmol; 2006; 34(1):44-50. PubMed ID: 16451258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etiology and clinical outcomes of microbial keratitis at a tertiary eye-care center in northern Thailand.
    Tananuvat N; Punyakhum O; Ausayakhun S; Chaidaroon W
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S8-17. PubMed ID: 22696846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
    Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
    Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daytime orthokeratology associated with infectious keratitis by multiple gram-negative bacilli: Burkholderia cepacia, Pseudomonas putida, and Pseudomonas aeruginosa.
    Ying-Cheng L; Chao-Kung L; Ko-Hua C; Wen-Ming H
    Eye Contact Lens; 2006 Jan; 32(1):19-20. PubMed ID: 16415688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas keratitis associated with continuous wear silicone-hydrogel soft contact lens: a case report.
    Lee KY; Lim L
    Eye Contact Lens; 2003 Oct; 29(4):255-7. PubMed ID: 14555905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical, microbiological and therapeutic features of severe bacterial keratitis].
    Darugar A; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 Jun; 34(6):362-8. PubMed ID: 21507512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.